Skip to main content
Top
Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 12/2017

01-12-2017 | Continuing Professional Development

Anesthetic implications of recreational drug use

Author: Pierre Beaulieu, MD, PhD, FRCA

Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Issue 12/2017

Login to get access

Abstract

Purpose

As the use of recreational drugs increases, the likelihood of an anesthesiologist perioperatively encountering patients using or addicted to these drugs will also increase.

Principal findings

Addicted patients may present for anesthetic care in a variety of circumstances in everyday elective surgeries or in acute or life-saving situations, such as emergency Cesarean delivery or trauma surgery. Therefore, it is important for anesthesiologists to know about the most common illicit drugs being used, their clinical presentation and side effects, and the anesthetic options that are beneficial or detrimental to these patients. The most frequently used illicit substances, apart from alcohol and tobacco, are cannabis, cocaine, heroin, prescription opioids, methamphetamine, and hallucinogens. When planning anesthetic care, it is important for anesthesiologists to understand the effects of these agents, including various drug interactions, to predict tolerance to some anesthetic agents, to recognize drug withdrawal signs and symptoms, and to be prepared to manage all these factors in the perioperative period.

Conclusions

For optimal patient care through the perioperative period, it is critical to obtain information about patient drug use and other associated treatment in order to construct an appropriate anesthetic plan, including specific considerations during surgery, emergence, and in the postanesthesia care unit.
Footnotes
1
“Crack” is the name given to cocaine that has been processed with baking soda or ammonia and transformed into a more potent smokable “rock” form.
 
2
Le « crack » est le nom donné à la cocaïne qui a été traitée avec du bicarbonate de soude ou de l’ammoniac pour être transformée en une forme « solide » plus puissante et fumable.
 
Literature
1.
go back to reference Hernandez M, Birnbach DJ, Van Zundert AA. Anesthetic management of the illicit-substance-using patient. Curr Opin Anaesthesiol 2005; 18: 315-24.CrossRefPubMed Hernandez M, Birnbach DJ, Van Zundert AA. Anesthetic management of the illicit-substance-using patient. Curr Opin Anaesthesiol 2005; 18: 315-24.CrossRefPubMed
2.
go back to reference Wong GT, Irwin MG. Poisoning with illicit substances: toxicology for the anaesthetist. Anaesthesia 2013; 68(Suppl 1): 117-24.CrossRefPubMed Wong GT, Irwin MG. Poisoning with illicit substances: toxicology for the anaesthetist. Anaesthesia 2013; 68(Suppl 1): 117-24.CrossRefPubMed
3.
go back to reference Vadivelu N, Mitra S, Kaye AD, Urman RD. Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient. Best Pract Res Clin Anaesthesiol 2014; 28: 91-101. CrossRefPubMed Vadivelu N, Mitra S, Kaye AD, Urman RD. Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient. Best Pract Res Clin Anaesthesiol 2014; 28: 91-101. CrossRefPubMed
4.
go back to reference Moran S, Isa J, Steinemann S. Perioperative management in the patient with substance abuse. Surg Clin North Am 2015; 95: 417-28. CrossRefPubMed Moran S, Isa J, Steinemann S. Perioperative management in the patient with substance abuse. Surg Clin North Am 2015; 95: 417-28. CrossRefPubMed
6.
go back to reference Neuman MG, Malnick S, Maor Y. Alcoholic liver disease: clinical and translational research. Exp Mol Pathol 2015; 99: 596-610.CrossRefPubMed Neuman MG, Malnick S, Maor Y. Alcoholic liver disease: clinical and translational research. Exp Mol Pathol 2015; 99: 596-610.CrossRefPubMed
9.
go back to reference Hilal-Dandan R, Brunton LL. Drug addiction. In: Hilal-Dandan R, Brunton LL, editors. Goodman & Gilman’s Manual of Pharmacology and Therapeutics. 2nd ed. NY: McGrawHill; 2014. p. 387-99. Hilal-Dandan R, Brunton LL. Drug addiction. In: Hilal-Dandan R, Brunton LL, editors. Goodman & Gilman’s Manual of Pharmacology and Therapeutics. 2nd ed. NY: McGrawHill; 2014. p. 387-99.
12.
go back to reference Leeman RF, Potenza MN. A targeted review of the neurobiology and genetics of behavioural addictions: an emerging area of research. Can J Psychiatry 2013; 58: 260-73.CrossRefPubMedPubMedCentral Leeman RF, Potenza MN. A targeted review of the neurobiology and genetics of behavioural addictions: an emerging area of research. Can J Psychiatry 2013; 58: 260-73.CrossRefPubMedPubMedCentral
14.
go back to reference Grueter BA, Rothwell PE, Malenka RC. Integrating synaptic plasticity and striatal circuit function in addiction. Curr Opin Neurobiol 2012; 22: 545-51.CrossRefPubMed Grueter BA, Rothwell PE, Malenka RC. Integrating synaptic plasticity and striatal circuit function in addiction. Curr Opin Neurobiol 2012; 22: 545-51.CrossRefPubMed
15.
go back to reference Kreek MJ, Levran O, Reed B, Schlussman SD, Zhou Y, Butelman ER. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest 2012; 122: 3387-93.CrossRefPubMedPubMedCentral Kreek MJ, Levran O, Reed B, Schlussman SD, Zhou Y, Butelman ER. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest 2012; 122: 3387-93.CrossRefPubMedPubMedCentral
16.
go back to reference Ouzir M, Errami M. Etiological theories of addiction: A comprehensive update on neurobiological, genetic and behavioural vulnerability. Pharmacol Biochem Behav 2016; 148: 59-68.CrossRefPubMed Ouzir M, Errami M. Etiological theories of addiction: A comprehensive update on neurobiological, genetic and behavioural vulnerability. Pharmacol Biochem Behav 2016; 148: 59-68.CrossRefPubMed
18.
go back to reference National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017: DOI: 10.17226/24625. National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017: DOI: 10.17226/24625.
19.
go back to reference Beaulieu P, Boulanger A, Desroches J, Clark AJ. Medical cannabis: considerations for the anesthesiologist and pain physician. Can J Anesth 2016; 63: 608-24.CrossRefPubMed Beaulieu P, Boulanger A, Desroches J, Clark AJ. Medical cannabis: considerations for the anesthesiologist and pain physician. Can J Anesth 2016; 63: 608-24.CrossRefPubMed
20.
go back to reference Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015; 313: 2456-73.CrossRefPubMed Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015; 313: 2456-73.CrossRefPubMed
21.
go back to reference Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. JAMA 2015; 313: 2474-83.CrossRefPubMed Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. JAMA 2015; 313: 2474-83.CrossRefPubMed
22.
go back to reference Meng H, Hanlon JG, Katznelson R, Ghanekar A, McGilvray I, Clarke H. The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation: a case report. Can J Anesth 2016; 63: 307-10.CrossRefPubMed Meng H, Hanlon JG, Katznelson R, Ghanekar A, McGilvray I, Clarke H. The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation: a case report. Can J Anesth 2016; 63: 307-10.CrossRefPubMed
23.
go back to reference Gardner EL. Cannabinoids and addiction. In: Pertwee RG, editor. Handbook of Cannabis. 1st ed. Oxford: Oxford University Press; 2014. p. 173-88.CrossRef Gardner EL. Cannabinoids and addiction. In: Pertwee RG, editor. Handbook of Cannabis. 1st ed. Oxford: Oxford University Press; 2014. p. 173-88.CrossRef
25.
27.
go back to reference Brookoff D, Campbell EA, Shaw LM. The underreporting of cocaine-related trauma: drug abuse warning network reports vs hospital toxicology tests. Am J Public Health 1993; 83: 369-71.CrossRefPubMedPubMedCentral Brookoff D, Campbell EA, Shaw LM. The underreporting of cocaine-related trauma: drug abuse warning network reports vs hospital toxicology tests. Am J Public Health 1993; 83: 369-71.CrossRefPubMedPubMedCentral
28.
go back to reference Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med 2015; 9: 358-67. CrossRefPubMedPubMedCentral Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med 2015; 9: 358-67. CrossRefPubMedPubMedCentral
29.
go back to reference Frank RG, Pollack HA. Addressing the fentanyl threat to public health. N Engl J Med 2017; 376: 605-7.CrossRefPubMed Frank RG, Pollack HA. Addressing the fentanyl threat to public health. N Engl J Med 2017; 376: 605-7.CrossRefPubMed
30.
go back to reference Brady KT, McCauley JL, Back SE. Prescription opioid misuse, abuse, and treatment in the United States: an update. Am J Psychiatry 2016; 173: 18-26.CrossRefPubMed Brady KT, McCauley JL, Back SE. Prescription opioid misuse, abuse, and treatment in the United States: an update. Am J Psychiatry 2016; 173: 18-26.CrossRefPubMed
31.
go back to reference Manchikanti L, Kaye AM, Kaye AD. Current State of Opioid Therapy and Abuse. Curr Pain Headache Rep 2016; 20: 34.CrossRefPubMed Manchikanti L, Kaye AM, Kaye AD. Current State of Opioid Therapy and Abuse. Curr Pain Headache Rep 2016; 20: 34.CrossRefPubMed
33.
go back to reference Volkow ND, McLellan AT. Opioid abuse in chronic pain - misconceptions and mitigation strategies. N Engl J Med 2016; 374: 1253-63.CrossRefPubMed Volkow ND, McLellan AT. Opioid abuse in chronic pain - misconceptions and mitigation strategies. N Engl J Med 2016; 374: 1253-63.CrossRefPubMed
34.
go back to reference Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health 2015; 36: 559-74.CrossRefPubMed Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health 2015; 36: 559-74.CrossRefPubMed
35.
go back to reference Barnett V, Twycross R, Mihalyo M, Wilcock R. Opioid antagonists. J Pain Symptom Manage 2014; 47: 341-52.CrossRefPubMed Barnett V, Twycross R, Mihalyo M, Wilcock R. Opioid antagonists. J Pain Symptom Manage 2014; 47: 341-52.CrossRefPubMed
36.
go back to reference Kleber HD. Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues Clin Neurosci 2007; 9: 455-70.PubMedPubMedCentral Kleber HD. Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues Clin Neurosci 2007; 9: 455-70.PubMedPubMedCentral
38.
go back to reference Morgan CJ, Curran HV. Independent Scientific Committee on Drugs. Ketamine use: a review. Addiction 2012; 107: 27-38.PubMed Morgan CJ, Curran HV. Independent Scientific Committee on Drugs. Ketamine use: a review. Addiction 2012; 107: 27-38.PubMed
39.
go back to reference Gorlin AW, Rosenfeld DM, Ramakrishna H. Intravenous sub-anesthetic ketamine for perioperative analgesia. J Anaesthesiol Clin Pharmacol 2016; 32: 160-7.CrossRefPubMedPubMedCentral Gorlin AW, Rosenfeld DM, Ramakrishna H. Intravenous sub-anesthetic ketamine for perioperative analgesia. J Anaesthesiol Clin Pharmacol 2016; 32: 160-7.CrossRefPubMedPubMedCentral
40.
go back to reference Sanacora G, Frye MA, McDonald W, et al. American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry 2017; 74: 399-405.CrossRefPubMed Sanacora G, Frye MA, McDonald W, et al. American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry 2017; 74: 399-405.CrossRefPubMed
41.
go back to reference Liu Y, Lin D, Wu B, Zhou W. Ketamine abuse potential and use disorder. Brain Res Bull 2016; 126: 68-73.CrossRefPubMed Liu Y, Lin D, Wu B, Zhou W. Ketamine abuse potential and use disorder. Brain Res Bull 2016; 126: 68-73.CrossRefPubMed
43.
go back to reference White MC. How MDMA’s pharmacology and pharmacokinetics drive desired effects and harms. J Clin Pharmacol 2014; 54: 245-52.CrossRef White MC. How MDMA’s pharmacology and pharmacokinetics drive desired effects and harms. J Clin Pharmacol 2014; 54: 245-52.CrossRef
45.
go back to reference Clemow DB, Walker DJ. The potential for misuse and abuse of medications in ADHD: a review. Postgrad Med 2014; 126: 64-81.CrossRefPubMed Clemow DB, Walker DJ. The potential for misuse and abuse of medications in ADHD: a review. Postgrad Med 2014; 126: 64-81.CrossRefPubMed
47.
go back to reference Flisberg P, Paech MJ, Shah T, Ledowski T, Kurowski I, Parsons R. Induction dose of propofol in patients using cannabis. Eur J Anaesthesiol 2009; 26: 192-5.CrossRefPubMed Flisberg P, Paech MJ, Shah T, Ledowski T, Kurowski I, Parsons R. Induction dose of propofol in patients using cannabis. Eur J Anaesthesiol 2009; 26: 192-5.CrossRefPubMed
48.
go back to reference Vaghari B, Baratta JL, Gandhi K. Perioperative approach to patients with opioid abuse and tolerance. Anesthesiol News 2013; 1-4. Vaghari B, Baratta JL, Gandhi K. Perioperative approach to patients with opioid abuse and tolerance. Anesthesiol News 2013; 1-4.
51.
go back to reference Alam A, Juurlink DN. The prescription opioid epidemic: an overview for anesthesiologists. Can J Anesth 2016; 63: 61-8.CrossRefPubMed Alam A, Juurlink DN. The prescription opioid epidemic: an overview for anesthesiologists. Can J Anesth 2016; 63: 61-8.CrossRefPubMed
52.
go back to reference Richebe P, Beaulieu P. Perioperative pain management in the patients treated with opioids: continuing professional development. Can J Anesth 2009; 56: 969-81. CrossRefPubMed Richebe P, Beaulieu P. Perioperative pain management in the patients treated with opioids: continuing professional development. Can J Anesth 2009; 56: 969-81. CrossRefPubMed
53.
54.
go back to reference Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Menge M, Schulte Am Esch J. Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine (“ecstasy”). Anesthesiology 2003; 99: 1132-6. Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Menge M, Schulte Am Esch J. Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine (“ecstasy”). Anesthesiology 2003; 99: 1132-6.
55.
go back to reference Wang RZ, Vashistha V, Kaur S, Houchens NW. Serotonin syndrome: preventing, recognizing, and treating it. Cleve Clin J Med 2016; 83: 810-7.CrossRefPubMed Wang RZ, Vashistha V, Kaur S, Houchens NW. Serotonin syndrome: preventing, recognizing, and treating it. Cleve Clin J Med 2016; 83: 810-7.CrossRefPubMed
Metadata
Title
Anesthetic implications of recreational drug use
Author
Pierre Beaulieu, MD, PhD, FRCA
Publication date
01-12-2017
Publisher
Springer US
Published in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Issue 12/2017
Print ISSN: 0832-610X
Electronic ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-017-0975-0

Other articles of this Issue 12/2017

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 12/2017 Go to the issue